Resectable Pancreatic Ductal Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Resectable Pancreatic Ductal Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc Study [Phase 2]
A Phase 2 clinical trial update for the PIONEER-Panc study evaluating new and emerging therapies for pancreatic cancer at various stages (re…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment [NA]
This clinical trial update describes a biomarker-focused study using tumor DNA and protein profiling to understand how pancreatic ductal ade…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy
An Emory University-led trial is exploring how dietary patterns and the fecal microbiome affect response to neoadjuvant chemotherapy in pati…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Nivolumab in Combination With Chemotherapy Pre-Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer [EARLY_Phase 1]
This early phase 1 trial evaluates nivolumab in combination with chemotherapy before surgery in patients with borderline resectable pancreat…